Indications and uses
temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever
temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever
do not take more than directed (see overdose warning ) adults and children 12 years and over take 2 caplets every 6 hours while symptoms last do not take more than 6 caplets in 24 hours, unless directed by a doctor do not use for more than 10 days unless directed by a doctor children under 12 years ask a doctor
store between 20-25 ° C (68-77 ° F) do not use if carton is opened or neck wrap or foil inner seal imprinted with "SAFETY SEAL®" is broken or missing
Drug Facts
Acetaminophen 500 mg
Pain reliever/fever reducer
This product contains acetaminophen.
Severe liver damage may occur if you take
Do not use
Ask a doctor before use if you have liver disease
Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin
Stop use and ask a doctor if
These could be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222) Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
| adults and children 12 years and over |
|
| children under 12 years | ask a doctor |
call 1-877-895-3665 (toll-free) or 215-273-8755 (collect)
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | 16 |
| 209459 | Tylenol Extra Strength 500 MG Oral Tablet | PSN | 16 |
| 209459 | acetaminophen 500 MG Oral Tablet [Tylenol] | SBD | 16 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | 16 |
| 198440 | APAP 500 MG Oral Tablet | SY | 16 |
| 209459 | APAP 500 MG Oral Tablet [Tylenol] | SY | 16 |
| 209459 | Tylenol 500 MG Oral Tablet | SY | 16 |
| 209459 | Tylenol Extra Strength 500 MG Oral Tablet | SY | 16 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50580-451-03 | TYLENOLExtra Strength | 1 in 1 POUCH | TABLET, COATED | 1 | 16 | |
| 50580-451-03 | TYLENOLExtra Strength | 150 in 1 CARTON | TABLET, COATED | 150 | 16 | |
| 50580-451-10 | TYLENOLExtra Strength | 10 in 1 CARTON | TABLET, COATED | 10 | 16 | |
| 50580-451-10 | TYLENOLExtra Strength | 10 in 1 BLISTER PACK | TABLET, COATED | 10 | 16 | |
| 50580-451-50 | TYLENOLExtra Strength | 1 in 1 CARTON | TABLET, COATED | 1 | 16 | |
| 50580-451-50 | TYLENOLExtra Strength | 50 in 1 BOTTLE, PLASTIC | TABLET, COATED | 50 | 16 | |
| 50580-451-70 | TYLENOLExtra Strength | 700 in 1 BOTTLE, PLASTIC | TABLET, COATED | 700 | 16 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-451-03 | EA - Each | 50580-451 | bf2d93f2-37e7-4940-95f0-3bbadd928c17 | 1 | 2012-07-24 |
| 50580-451-10 | EA - Each | 50580-451 | ae3ddd38-7acf-4ba2-a13f-e679753e429a | 1 | 2014-07-02 |
| 50580-451-50 | EA - Each | 50580-451 | ad97324f-9fc5-437d-9fa7-a55ff960df73 | 1 | 2012-07-24 |
| 50580-451-70 | EA - Each | 50580-451 | 5b285dd0-2a68-4fbf-9f61-d7a31c6ec5bb | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Acetaminophen | ACTIVE INGREDIENT | 362O9ITL9D | 5 | |
| Acetaminophen | ACTIVE MOIETY | 362O9ITL9D | 5 | |
| aluminum oxide | INACTIVE INGREDIENT | LMI26O6933 | 5 | |
| Carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | 5 | |
| castor oil | INACTIVE INGREDIENT | D5340Y2I9G | 5 | |
| FD&C red No. 40 | INACTIVE INGREDIENT | WZB9127XOA | 5 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 5 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 5 | |
| Polyethylene glycols | INACTIVE INGREDIENT | 3WJQ0SDW1A | 5 | |
| powdered cellulose | INACTIVE INGREDIENT | SMD1X3XO9M | 5 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 5 | |
| shellac | INACTIVE INGREDIENT | 46N107B71O | 5 | |
| Sodium Starch Glycolate Type A Potato | INACTIVE INGREDIENT | 5856J3G2A2 | 5 | |
| starch, corn | INACTIVE INGREDIENT | O8232NY3SJ | 5 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50580-451 | 50580-451-03, 50580-451-10, 50580-451-50, 50580-451-70 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, COATED / ORAL | 207.5 mg | ||
| Carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, COATED / ORAL | 207.5 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| shellac | SHELLAC | 46N107B71O | TABLET, COATED / ORAL | 30 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| FD&C red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, COATED / ORAL | 0.1 mg | ||
| FD&C red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, COATED / ORAL | 0.1 mg | ||
| FD&C red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, COATED / ORAL | 0.1 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, COATED / ORAL | 40.2 mg | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| shellac | SHELLAC | 46N107B71O | TABLET, COATED / ORAL | 30 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, COATED / ORAL | 40.2 mg | ||
| starch, corn | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, COATED / ORAL | 40.2 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| shellac | SHELLAC | 46N107B71O | TABLET, COATED / ORAL | 30 mg | ||
| FD&C red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, COATED / ORAL | 0.1 mg | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| starch, corn | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| FD&C red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, COATED / ORAL | 0.1 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| shellac | SHELLAC | 46N107B71O | TABLET, COATED / ORAL | 30 mg | ||
| Carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, COATED / ORAL | 207.5 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, COATED / ORAL | 40.2 mg | ||
| Carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, COATED / ORAL | 207.5 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| starch, corn | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| powdered cellulose | POWDERED CELLULOSE | SMD1X3XO9M | TABLET, COATED / ORAL | 40.2 mg | ||
| starch, corn | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| starch, corn | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| Carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, COATED / ORAL | 207.5 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| shellac | SHELLAC | 46N107B71O | TABLET, COATED / ORAL | 30 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TYLENOL Extra Strength | ACETAMINOPHEN | Kenvue Brands LLC | bb6533e5-e6a9-488c-b8ab-a6a06e87ede9 | 2025-02-18 | Warnings | 50580-451-03 50580-451-70 50580-451-10 50580-451-50 50580-451 50580045170 50580045150 50580045103 50580045110 2d87c8e1-e743-56cc-e063-6394a90aac79 bb6533e5-e6a9-488c-b8ab-a6a06e87ede9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.